| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer
1 company
Robert Thomas Freeman last filed a Form 4 in March 2025, as Chief Financial Officer at ALHC. From March 2021 to March 2025, the filings on record show 0 open-market purchases and 32 sales. Robert Thomas Freeman's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
Historically, Robert Thomas Freeman's trades have earned a middling insider score of 58/100 across 44 rated trades. Over a 12-month horizon, 47.7% of those trades were profitable, with an average 12-month return of -2.9%.
At the last filing, the largest reported position was 1,464,419 shares of ALHC. The ALHC filings lean toward selling, a net 1,376,173 shares.
Shares as reported in the last Form 4 for each company; the most recent is from March 2025. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 20, 2021 | ALHC Alignment Healthcare, Inc. | Chief Financial Officer | Sell | 23,000 | $19.38 | $445,763.00 | -2.7% | -60.5% | -39.9% | |
| Apr 6, 2021 | ALHC Alignment Healthcare, Inc. | Chief Financial Officer | Sell | 38,919 | $16.83 | $655,006.77 | -4.2% | -2.6% | -52.3% |